Dian Diagnostics Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	9,971	10,089	12,196	13,407	20,281	13,079
Other Revenue	7.28	7.28	0.37	1.36	1.71	3.6
Revenue	9,978	10,096	12,196	13,408	20,282	13,083
Revenue Growth (YoY)	-13.90%	-17.22%	-9.04%	-33.89%	55.03%	22.85%
Cost of Revenue	7,104	7,261	8,811	9,256	12,809	8,100
Gross Profit	2,873	2,835	3,385	4,152	7,473	4,983
Selling, General & Admin	1,832	1,850	2,049	2,300	2,834	2,296
Research & Development	247.83	254.54	305.88	432.64	638.47	424.75
Other Operating Expenses	40.05	39.96	39.36	30.44	56.17	44.65
Operating Expenses	2,244	2,341	2,839	3,139	3,817	2,856
Operating Income	628.93	494.28	546.34	1,013	3,657	2,127
Interest Expense	-151.41	-161.46	-203.03	-250.6	-274.73	-230.2
Interest & Investment Income	50.97	50.54	64.38	41.76	69.62	77.47
Currency Exchange Gain (Loss)	-4.8	-4.8	-2.02	0.84	-25.12	-2.33
Other Non Operating Income (Expenses)	-24.77	-12.28	-51.33	-24.48	-38.46	-15.49
EBT Excluding Unusual Items	498.92	366.28	354.35	780.65	3,388	1,956
Impairment of Goodwill	-83.96	-83.96	-377.97	-	-589.64	-
Gain (Loss) on Sale of Investments	-1.87	3.53	-28.72	-18.32	-56.24	-187.72
Gain (Loss) on Sale of Assets	1.18	-0.18	-1.48	-3.57	-11.18	6.35
Asset Writedown	-15.26	-15.62	-13.14	-25.72	-242.16	-21.53
Legal Settlements	-	-	-	-	-	-7.59
Other Unusual Items	-8.86	-13.85	15.13	65.29	54.74	45.1
Pretax Income	390.16	256.19	-51.83	798.33	2,544	1,791
Income Tax Expense	144.51	110.58	117.41	216.74	681.09	307.4
Earnings From Continuing Operations	245.65	145.61	-169.23	581.59	1,862	1,484
Minority Interest in Earnings	-116.22	-101.55	-188.04	-274.13	-428.28	-320.72
Net Income	129.43	44.05	-357.28	307.46	1,434	1,163
Net Income to Common	129.43	44.05	-357.28	307.46	1,434	1,163
Net Income Growth	-	-	-	-78.56%	23.33%	44.83%
Shares Outstanding (Basic)	611	611	617	625	623	620
Shares Outstanding (Diluted)	611	611	617	625	624	624
Shares Change (YoY)	-0.39%	-0.98%	-1.30%	0.18%	-0.02%	0.43%
EPS (Basic)	0.21	0.07	-0.58	0.49	2.30	1.87
EPS (Diluted)	0.21	0.07	-0.58	0.49	2.30	1.86
EPS Growth	-	-	-	-78.60%	23.36%	44.21%
Free Cash Flow	1,784	1,743	844.2	1,220	691.64	728.42
Free Cash Flow Per Share	2.92	2.85	1.37	1.95	1.11	1.17
Dividend Per Share	0.350	0.350	0.900	0.060	0.200	0.135
Dividend Growth	-61.11%	-61.11%	1400.00%	-70.00%	48.15%	3.85%
Gross Margin	28.80%	28.08%	27.75%	30.97%	36.85%	38.09%
Operating Margin	6.30%	4.90%	4.48%	7.56%	18.03%	16.26%
Profit Margin	1.30%	0.44%	-2.93%	2.29%	7.07%	8.89%
Free Cash Flow Margin	17.88%	17.26%	6.92%	9.10%	3.41%	5.57%
EBITDA	886.73	779.77	942.66	1,467	4,247	2,468
EBITDA Margin	8.89%	7.72%	7.73%	10.94%	20.94%	18.87%
D&A For EBITDA	257.79	285.5	396.32	453.51	590.21	341.57
EBIT	628.93	494.28	546.34	1,013	3,657	2,127
EBIT Margin	6.30%	4.90%	4.48%	7.56%	18.03%	16.26%
Effective Tax Rate	37.04%	43.16%	-	27.15%	26.78%	17.16%
Revenue as Reported	9,978	10,096	12,196	13,408	20,282	13,083
Advertising Expenses	-	50.14	59.27	68.34	76.59	59.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.